Paradoxical Reaction to Golimumab: Tumor Necrosis Factor α Inhibitor Inducing Psoriasis Pustulosa

Paradoxical Reaction to Golimumab: Tumor Necrosis Factor α Inhibitor Inducing Psoriasis Pustulosa

Importance: Golimumab is a human monoclonal antibody, used for rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis. Adverse reactions are increasing with this class of medication (tumor necrosis factor α inhibitors). Observations: The authors present a case of a female patient who p...

Full description

Bibliographic Details
Main Authors: Marien Siqueira Soto Lopes, Beatriz Moritz Trope, Maria Paula Rua Rochedo Rodriguez, Rachel Lima Grynszpan, Tullia Cuzzi, Marcia Ramos-e-Silva
Format: Article
Language:English
Published: Karger Publishers 2013-11-01
Series:Case Reports in Dermatology
Subjects:
Golimumab
Psoriasis pustulosa
Tumor necrosis factor α inhibitor
Paradoxical reaction
Online Access:http://www.karger.com/Article/FullText/350930

Internet

http://www.karger.com/Article/FullText/350930

Similar Items